These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1376734)

  • 1. Human neutrophil-derived histamine-releasing activity (HRA-N) causes the release of serotonin but not arachidonic acid metabolites from rat basophilic leukemia cells.
    Igarashi Y; Lundgren JD; Doerfler ME; Shelhamer JH; Kaliner MA; White MV
    J Allergy Clin Immunol; 1992 Jun; 89(6):1085-97. PubMed ID: 1376734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrocortisone inhibits rat basophilic leukemia cell mediator release induced by neutrophil-derived histamine releasing activity as well as by anti-IgE.
    White MV; Igarashi Y; Lundgren JD; Shelhamer J; Kaliner M
    J Immunol; 1991 Jul; 147(2):667-73. PubMed ID: 1712816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhibitors of arachidonic acid metabolism on serotonin release from rat basophilic leukemia cells.
    Igarashi Y; Lundgren JD; Shelhamer JH; Kaliner MA; White MV
    Immunopharmacology; 1993; 25(2):131-44. PubMed ID: 8500985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
    White MV; Kaplan AP; Haak-Frendscho M; Kaliner M
    J Immunol; 1988 Nov; 141(10):3575-83. PubMed ID: 2460539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils and mast cells: characterization of cells responsive to neutrophil-derived histamine-releasing activity (HRA-N).
    White MV; Baer H; Kubota Y; Kaliner M
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):773-80. PubMed ID: 2478609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
    Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
    J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils and mast cells: nedocromil sodium inhibits the generation of neutrophil-derived histamine-releasing activity (HRA-N).
    White MV; Phillips RL; Kaliner MA
    J Allergy Clin Immunol; 1991 Apr; 87(4):812-20. PubMed ID: 1707428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release.
    Conti P; Reale M; Barbacane RC; Panara MR; Bongrazio M; Theoharides TC
    Immunol Lett; 1992 Apr; 32(2):117-23. PubMed ID: 1612634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    Undem BJ; Peachell PT; Lichtenstein LM
    J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonate-induced eicosanoid synthesis in RBL-2H3 cells: stimulation with antigen or A23187 induces prolonged activation of 5-lipoxygenase.
    Westcott JY; Wenzel SE; Dreskin SC
    Biochim Biophys Acta; 1996 Sep; 1303(1):74-81. PubMed ID: 8816855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule.
    Wantke F; MacGlashan DW; Langdon JM; MacDonald SM
    J Allergy Clin Immunol; 1999 Apr; 103(4):642-8. PubMed ID: 10200014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli.
    Warner JA; Peters SP; Lichtenstein LM; Hubbard W; Yancey KB; Stevenson HC; Miller PJ; MacGlashan DW
    J Leukoc Biol; 1989 Jun; 45(6):558-71. PubMed ID: 2470847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophils and mast cells. I. Human neutrophil-derived histamine-releasing activity.
    White MV; Kaliner MA
    J Immunol; 1987 Sep; 139(5):1624-30. PubMed ID: 2442251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
    Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic modulation of the IgE or Ca2+ ionophore A23187 mediated Ca2+ influx, phospholipase activation, and histamine release in rat basophilic leukemia cells.
    Urata C; Siraganian RP
    Int Arch Allergy Appl Immunol; 1985; 78(1):92-100. PubMed ID: 2411672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).
    Ezeamuzie CI; Assem ES
    Immunopharmacology; 1990; 20(1):31-43. PubMed ID: 1699910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chinese herbal medicine, shinpi-to, inhibits IgE-mediated leukotriene synthesis in rat basophilic leukemia-2H3 cells.
    Hamasaki Y; Kobayashi I; Hayasaki R; Zaitu M; Muro E; Yamamoto S; Ichimaru T; Miyazaki S
    J Ethnopharmacol; 1997 Apr; 56(2):123-31. PubMed ID: 9174973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3).
    Berthon B; Taudou G; Combettes L; Czarléwski W; Carmi-Leroy A; Marchand F; Weyer A
    Biochem Pharmacol; 1994 Mar; 47(5):789-94. PubMed ID: 7510965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.